<DOC>
	<DOCNO>NCT00778349</DOCNO>
	<brief_summary>To assess food effect pharmacokinetic profile metformin liquid 100 mg/mL Ranbaxy Laboratories healthy , adult , human subjecis follow dose administration 10 mL ( 1000 mg ) fasting condition , Iow fat meal high fat meal</brief_summary>
	<brief_title>A Comparitive Bioavailability Study Metformin Hydrochloride Liquid 500mg/ 5 mL Under Fasting Conditions After Low High Fat Meal</brief_title>
	<detailed_description>This study open label , randomize , three-treatment , three-period , six-sequence , single-dose , crossover pharmacokinetic study plan 36 healthy , adult , human subject fast condition . However 34 subject enrol 33 subject complete period study . All period separate washout seven day As per protocol ( Appendix 1 ) , enough healthy , adult , human subject enrol study allow dose 36 subject first period . 34 subject enrol 33 subject complete period study</detailed_description>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>1 . Be age range 18.45 year . 2 . Be neither overweight underweight his/her height per Life Insurance Corporation India height/weight chart nonmedical case . 3 . Have voluntarily give write informed consent participate study . 4 . Be normal health determine medical history physical 5 . Examination subject perform .within 28 day prior commencement study . 6 . If female : Of childbearing potential , practice acceptable method birth control duration study judge investigator ( ) , condom , foam , jelly , diaphragm , intrauterine device ( IUD ) , abstinence ; or~ Is postmenopausal least 1 year ; Is surgically sterile bilateral tubal ligation , bilateral oophorectomy , hysterectomy ) . 1 . History allergy metformin relate antidiabetic biguanide preparation . 2 . Any evidence organ dysfunction clinically significant deviation normal , physical clinical determination . 3 . Presence disease marker HIV 1 2 , Hepatitis B C viruses syphilis infection . 4 . Female volunteer demonstrate positive pregnancy screen . 5 . Female volunteer currently breastfeed . 6 . Presence value ' clinically significantly different normal reference range hemoglobin , total white blood cell count , differential WBC count platelet count 7 . Positive urinary screen test drug abuse ( opiates cannabinoids 8 . Presence value significantly different normal.reference range ( define Appendix 5 ) se rum creatinine , blood urea nitrogen serum aspartate aminotransferase ( AST ) , serum alanine aminotranferase ( ALT ) , serum alkaline phosphatase , serum billrubin , plasma glucose serum cholesterol 9 . Clinically abnormal chemical microscopic examination urine define presence RBC , WBC ( &gt; 4/HPF ) , epithelial cell ( &gt; 4/HPF ) , glucose , ( positive ) protein ( positive ) . 10 . History serious gastrointestinal , hepatic , renal , cardiovascular , pulmonary , neurological hematological disease , diabetes glaucoma . 11 . History psychiatric illness . may impair ability provide write informed consent . 12 . Regular smoker smoke 10 cigarette daily difficulty abstain smoke duration study period . 13 . History drug dependence excessive alcohol intake habitual basis 2 unit alcoholic beverage per day ( 1 'unit equivalent half pint beer 1 glass wine 1 measure spirit ) difficulty abstain duration study period . 14 . Use enzyme modifying drug within 30 day prior Day I study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Bioavailability Metformin solution 100 mg/mL</keyword>
</DOC>